FDA Inspection 722282 — Lonza Biologics, Inc.

Lonza Biologics, Inc. — FEI 3001701602

The FDA completed an inspection of Lonza Biologics, Inc. on May 6, 2011 in Hopkinton, MA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 6, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hopkinton, MA (United States)